Our research on Tousled-like kinase 1 (TLK1) and the development of J54 represent promising breakthroughs, targeting the TLK1-NEK1-ATR-Chk1 and NEK1 > YAP pathways to drive apoptosis and prevent resistance in advanced PCa. The gene discussed is CHEK1; the disease is posterior cortical atrophy.